In dermatology, it is highly prized for its ability to brighten skin from the inside out
Br J Pharmacol 179(4):659676 Hernandez AF, Green JB, Janmohamed S, DAgostino Sr RB, Granger CB, Jones NP, et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
If we as a society think obesity is a problem that warrants addressing with drug coverage, then we need to ask the question, how do we do that equitably? the medical director said
Hirsch et al
IGF-1 DES is a truncated version (des(1-3)IGF-1) that has higher potency at the receptor (~5-10x) but a very short half-life (~2030 minutes)
Dermatitis 2006;17(4):196-197